236 related articles for article (PubMed ID: 36535465)
21. Thymic stromal lymphopoietin: a central regulator of allergic asthma.
Watson B; Gauvreau GM
Expert Opin Ther Targets; 2014 Jul; 18(7):771-85. PubMed ID: 24930783
[TBL] [Abstract][Full Text] [Related]
22. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent.
Salter BM; Oliveria JP; Nusca G; Smith SG; Watson RM; Comeau M; Sehmi R; Gauvreau GM
J Allergy Clin Immunol; 2015 Dec; 136(6):1636-1644. PubMed ID: 25962901
[TBL] [Abstract][Full Text] [Related]
23. Positioning of Tezepelumab in Severe Asthma.
Miralles-López JC; Antolín-Amérigo D; García-Moguel I; Domínguez-Ortega J; Delgado-Romero J; Quirce S
J Investig Allergol Clin Immunol; 2024 Feb; 34(1):1-11. PubMed ID: 37812191
[TBL] [Abstract][Full Text] [Related]
24. CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
Emson C; Diver S; Chachi L; Megally A; Small C; Downie J; Parnes JR; Bowen K; Colice G; Brightling CE
Respir Res; 2020 Oct; 21(1):265. PubMed ID: 33050900
[TBL] [Abstract][Full Text] [Related]
25. Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM; Bergeron C; Boulet LP; Cockcroft DW; Côté A; Davis BE; Leigh R; Myers I; O'Byrne PM; Sehmi R
Allergy; 2023 Feb; 78(2):402-417. PubMed ID: 36463491
[TBL] [Abstract][Full Text] [Related]
26. Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma.
Mahmutovic-Persson I; Akbarshahi H; Bartlett NW; Glanville N; Johnston SL; Brandelius A; Uller L
Allergy; 2014 Mar; 69(3):348-58. PubMed ID: 24283976
[TBL] [Abstract][Full Text] [Related]
27. Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma.
Lee HY; Lee HY; Hur J; Kang HS; Choi JY; Rhee CK; Kang JY; Kim YK; Lee SY
Korean J Intern Med; 2020 May; 35(3):619-629. PubMed ID: 32183504
[TBL] [Abstract][Full Text] [Related]
28. Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma.
Zhang K; Feng Y; Liang Y; Wu W; Chang C; Chen D; Chen S; Gao J; Chen G; Yi L; Cheng D; Zhen G
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33945508
[TBL] [Abstract][Full Text] [Related]
29. A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells.
Zhang F; Huang G; Hu B; Song Y; Shi Y
Clin Exp Immunol; 2011 May; 164(2):256-64. PubMed ID: 21352203
[TBL] [Abstract][Full Text] [Related]
30. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
[TBL] [Abstract][Full Text] [Related]
31. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite.
Chen ZG; Zhang TT; Li HT; Chen FH; Zou XL; Ji JZ; Chen H
PLoS One; 2013; 8(1):e51268. PubMed ID: 23300949
[TBL] [Abstract][Full Text] [Related]
32. Role of thymic stromal lymphopoietin in allergy and beyond.
Ebina-Shibuya R; Leonard WJ
Nat Rev Immunol; 2023 Jan; 23(1):24-37. PubMed ID: 35650271
[TBL] [Abstract][Full Text] [Related]
33. Thymic stromal lymphopoietin: a new cytokine in asthma.
Rochman Y; Leonard WJ
Curr Opin Pharmacol; 2008 Jun; 8(3):249-54. PubMed ID: 18450510
[TBL] [Abstract][Full Text] [Related]
34. TSLP Inhibitors for Asthma: Current Status and Future Prospects.
Matera MG; Rogliani P; Calzetta L; Cazzola M
Drugs; 2020 Apr; 80(5):449-458. PubMed ID: 32078149
[TBL] [Abstract][Full Text] [Related]
35. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.
Yu G; Zhang Y; Wang X; Sai L; Bo C; Yeo AJ; Lavin MF; Peng C; Jia Q; Shao H
Toxicol Lett; 2019 Dec; 317():59-67. PubMed ID: 31577921
[TBL] [Abstract][Full Text] [Related]
36. Multifactorial Causes and Consequences of TLSP Production, Function, and Release in the Asthmatic Airway.
Brister DL; Omer H; Whetstone CE; Ranjbar M; Gauvreau GM
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672419
[TBL] [Abstract][Full Text] [Related]
37. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases.
Wang WL; Li HY; Zhang MS; Gao PS; He SH; Zheng T; Zhu Z; Zhou LF
Int Arch Allergy Immunol; 2013; 160(1):18-26. PubMed ID: 22948028
[TBL] [Abstract][Full Text] [Related]
38. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
[TBL] [Abstract][Full Text] [Related]
39. Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response.
Duchesne M; Okoye I; Lacy P
Front Immunol; 2022; 13():975914. PubMed ID: 36311787
[TBL] [Abstract][Full Text] [Related]
40. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
